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Abstract
Introduction: Degeneration of the intervertebral disc (IVD) is characterized by marked degradation and
restructuring of the annulus fibrosus (AF). Although several matrix metalloproteinases (MMPs) have been found to
be more prevalent in degenerate discs, their coordination and function within the context of the disease process
are still not well understood. In this study, we sought to determine whether MMP-2 is associated with
degenerative changes in the AF and to identify the manner by which AF cells use MMP-2.
Methods: Two established animal models of disc degeneration, static compression and transannular needle
puncture of rodent caudal discs, were examined for MMP-2 immunopositivity. With lentiviral transduction of an
shRNA expression cassette, we screened and identified an effective shRNA sequence for generating stable RNA
interference to silence MMP-2 expression in primary rat AF cells. Gelatin films were used to compare gelatinase
activity and spatial patterns of degradation between transduced cells, and both noninfected and nonsense shRNA
controls. The functional significance of MMP-2 was determined by assessing the ability for cells to remodel
collagen gels.
Results: Both static compression and 18-g annular puncture of rodent caudal discs stimulated an increase in MMP-
2 activity with concurrent lamellar disorganization in the AF, whereas 22-g and 26-g needle injuries did not. To
investigate the functional role of MMP-2, we established lentivirus-mediated RNAi to induce stable knockdown of
transcript levels by as much as 88%, and protein levels by as much as 95% over a 10-day period. Culturing
transduced cells on gelatin films confirmed that MMP-2 is the primary functional gelatinase in AF cells, and that
MMP-2 is used locally in regions immediately around AF cells. In collagen gels, transduced cells demonstrated an
inability to remodel collagen matrices.
Conclusions: Our study indicates that increases in MMP-2 observed in human degenerate discs are mirrored in
experimentally induced degenerative changes in rodent animal models. AF cells appear to use MMP-2 in a very
directed fashion for local matrix degradation and collagen remodeling. This suggests that MMP-2 may have a
functionally significant role in the etiology of degenerative disc disease and could be a potential therapeutic target.
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Introduction
Various physiologic and pathophysiologic processes of
connective tissues involve cell-mediated matrix-remodel-
ing events, including tissue growth, repair, and degen-
eration. During remodeling, extracellular matrix (ECM)
turnover rates are increased [1], causing shifts in tissue
architecture and composition. Although a number of
molecules are thought to regulate this process, matrix
metalloproteinases (MMPs) are believed to be particu-
larly important in ECM degradation [2-4]. In addition to
being the key mediators of tissue remodeling, MMPs are
also known to be involved in cell proliferation, migra-
tion, differentiation, angiogenesis, apoptosis, and host
defense [5].
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A notable example of chronic pathophysiologic remo-
deling occurs in the intervertebral disc (IVD) of the
spine during degenerative disc disease (DDD). In the
annulus fibrosus (AF), there is an acceleration of age-
related matrix changes, which are thought to be caused
by enhancement of catabolic processing of the ECM
[3,4,6,7]. Several MMPs have been shown to be
expressed at elevated levels in the AF of diseased discs
[2]. One of these is MMP-2, a gelatinase that partici-
pates in the secondary breakdown of collagen during
remodeling [2,4,8,9]. Activation of MMP-2 above endo-
genous baseline levels has been found to be induced by
mechanical stress [10,11]. However, the functional roles
of MMP-2 in disc health and degeneration remain
unclear. An improved understanding of the molecular
mechanisms involved in DDD would contribute to the
development of interventional strategies [7] to mitigate
degenerative processes.
In recent years, RNA interference (RNAi) has become
a powerful and accessible tool for manipulating cellular
function, particularly with the use of small RNAs for
sequence-specific gene silencing [12,13]. Although
extensive studies are required to elucidate unanticipated
effects, the capability of RNAi to induce both transient
and stable silencing [12,14] contribute to its promise as
a technology for treating human disease.
We had previously observed that mechanical overloading
of murine IVDs results in altered MMP-2 activation pat-
terns [10,15]. As a first step toward improving our under-
standing of MMPs in DDD, this study demonstrates that,
in a rat annular-injury model of degenerative changes,
discs similarly exhibit an upregulation of MMP-2. To
investigate the functional implications of MMP-2, we then
validated an approach to silence MMP-2 gene expression
by using lentivirus-mediated RNAi in rat AF primary cell
cultures. We found that MMP-2 silencing inhibited degra-
dation of gelatin immediately surrounding cells and
impaired the ability of cells to remodel collagen gels. To
our knowledge, this is the first study to use small-hairpin
RNAs (shRNAs) to achieve stable knockdown of MMP-2.
Results suggest that MMP-2 is used locally by cells to drive
changes in ECM structure and function.
Materials and methods
Surgical procedure
Sprague-Dawley rats (6 to 9 months old; Taconic Farms,
Germantown, NY, USA) were subjected to annular punc-
ture to induce degenerative changes [16], after approval
from the Institutional Animal Care and Use Committee at
the University of Maryland, College Park. Rats were
anesthetized by using isoflurane, and the c6-7 motion seg-
ment was identified, marked, and confirmed by using
fluoroscopy. A subcutaneous injection of analgesic (bupre-
norphine, 0.03 mg/0.1 ml) and an intramuscular injection
of antibiotic (fluoroquinolone, 2.5 mg/0.1 ml) were given
to the rat. The diameter of the tail at the puncture site was
measured with calipers to determine the necessary depth
of needle insertion. After establishing a sterile field and
scrubbing with povidone/iodine (Betadine)-isopropyl alco-
hol, a cranial-caudal skin incision was made on the dorsal
aspect of the tail in the proximity of c6-7. Soft tissues were
parted to identify the c6-7 disc, and a sterile tapered hypo-
dermic needle (26-g, 22-g, or 18-g) was marked to the
depth corresponding to the radius of the tissue, and then
carefully inserted by hand. Fluoroscopy was used to con-
firm proper position and depth. For sham surgeries, the
skin incision was made, but discs were left uninjured. Inci-
sions were then sutured closed. After surgery, rats were
revived and returned to normal cage activity for 2 weeks,
with daily observation for pain and distress. Rats were initi-
ally given an injection of analgesic (buprenorphine,
0.03 mg/0.1 ml), after which analgesic (buprenorphine at
0.05 mg/kg rat), antiinflammatory (Carprofen at 5 mg/kg
rat), and antibiotic (cephalexin at 60 mg/kg rat) were admi-
nistered, if necessary, in accordance with our pain/distress
assessments and consultation with the veterinarian.
Immunohistochemistry
After 2 weeks, the rats were killed by carbon dioxide
asphyxiation (6 to 8 L/min until loss of consciousness, fol-
lowed by 12 L/min for 10 minutes) and bilateral thoracot-
omy. Motion segments were then dissected from tails, and
then fixed in formalin, decalcified in a solution containing
10% (wt/vol) sodium citrate and 20% formic acid, and pro-
cessed in graded ethanol and xylene baths before paraffin
embedding (TP1020/EG1160; Leica Microsystems, Buffalo
Grove, IL, USA). Paraffin blocks were sectioned at 6 μm
by using a microtome (HM355; Microm/Thermo Fisher
Scientific, Waltham, MA, USA). Slides containing serial
sections close to the midsagittal regions of punctured or
control discs were deparaffinized and rehydrated. Sections
were blocked with goat serum for 1 hour, washed, and
then incubated with primary antibody against MMP-2
(clone SPM346; Abcam, Cambridge, MA, USA) at either 0
(no Ab control), 1, or 10 μg/ml. A biotin-labeled goat anti-
mouse IgG secondary antibody was used with horseradish
peroxidase-conjugated streptavidin (Vectastain ABC; Vec-
tor Laboratories, Burlingame, CA, USA), and 3,3 -diami-
nobenzidine substrate to develop a color reaction. Each
batch of 26-g, 22-g, 18-g, and nonpunctured discs was
immunostained concurrently under identical conditions,
and images were captured under identical exposure condi-
tions to ensure valid qualitative comparisons of staining
intensity.
Primary cell isolation and culture
Healthy AF tissues were freshly harvested under sterile con-
ditions from Sprague-Dawley rat caudal discs immediately
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after euthanasia, performed as described earlier according
to procedures approved by the Institutional Animal Care
and Use Committee at the University of Maryland, College
Park. Tissues were minced and digested overnight in cul-
ture media containing 3 mg/ml collagenase. Digests were
then centrifuged, and cells were resuspended in fresh cul-
ture media and plated in tissue-culture flasks. Cells were
cultured until passage 3 in DMEM containing 10% FBS,
100 U/ml penicillin, and 100 µg/ml streptomycin at 37°C
with 5% CO2, with media changes 3 times per week.
In preliminary experiments, we found that rat AF cells
express similar levels of types I and II collagen, sox9,
and aggrecan during low-passage culture. Passage 3 cells
were selected as a balance between adequate cell expan-
sion and retention of cell phenotype.
Lentivirus construct preparation
Five 21- to 23-nt long sequences (Table 1) were identified
from the rat MMP2 mRNA [GenBank: NM_031054] for
designing candidate shRNA constructs (designated
shMMP2a-e). Stem-loop-stem sequences corresponding
to each shRNA construct were cloned into pENTR/U6
(Invitrogen, Carlsbad, CA, USA), which drives production
of shRNA through a human U6 expression cassette.
Plasmids were then genetically recombined with pLenti6/
BLOCK-iT-DEST (Invitrogen), which confers blasticidin
resistance. A nonsense control (shNon), containing a
scrambled sequence, was also cloned. Replication-deficient
lentivirus was then produced by packaging the vector in
293FT embryonic kidney cells by using Lipofectamine
2000 and manufacturer-supplied packaging mix (Invitro-
gen). Virus-containing supernatants were harvested
72 hours later, sterile filtered, and stored at -80°C. Experi-
ments used either a mix of transduced and nontransduced
cells, or a blasticidin-purified population of transduced
cells.
Cell transduction
AF cells were plated in six-well tissue-culture plates in
complete media (DMEM, supplemented with 10% FBS
and 1% penicillin-streptomycin; Gibco/Invitrogen, Carls-
bad, CA, USA) at 50% confluence (150,000 cells/well).
Each of the six viral constructs (shMMP2a-e, shNon)
was added to one well each, at multiplicity of infection
(MOI) of 0.1, along with 6 µg/ml Polybrene (Sigma, St.
Louis, MO, USA) to facilitate transduction. Viral parti-
cles were removed the next day through aspiration of
the culture medium, and replaced with complete culture
medium. Blasticidin (Invitrogen) was added in appropri-
ate samples to select for transduced cells the day after
virus removal, at a concentration of 8 μg/ml, based on
preliminary experiments of AF cell sensitivity to blastici-
din. Media was changed every 3 days. In appropriate
samples, each media change contained blasticidin. Each
time point also included a corresponding noninfected
control (plated cells not exposed to viral particles).
Three separate experiments were conducted to deter-
mine MMP2 expression for each of the five shMMP viral
constructs. Experiment 1 was conducted to determine the
mixed-population response. As such, cells were infected
and harvested at 1, 4, 7, and 10 days after virus removal
without selection. Experiment 2 examined the response of
the pure transduced cell population. After infection, cells
were harvested at 1, 4, 7, and 10 days under continuous
blasticidin treatment. Experiment 3 assessed the stability
of gene silencing by subjecting cells to a 10-day continu-
ous blasticidin treatment, followed by culture in blastici-
din-free complete media for an additional 1, 4, 7, and 10
days. At each time point, samples were collected in Tris-
HCl, pH 7.5 to 8.0 by using a cell scraper. Each harvested
sample was divided into three groups to measure (a) DNA
content, (b) MMP-2 content, and (c) gene expression.
Conditioned media was also harvested from samples for
Table 1 Matrix metalloproteinase 2 (MMP-2) shRNA sequences
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measurement of MMP-2 content. All samples were main-
tained at -80°C until use.
MMP2 expression
MMP-2 content was quantified by using a microplate-
based activity assay (R&D Systems Inc., Minneapolis,
MN, USA). One fourth (25%) of each harvested sample
(see Cell transduction) was thawed, pulverized with a
pestle, and then loaded into microplates along with con-
ditioned media samples and standards. Protein levels of
MMP-2 were obtained according to the manufacturer’s
protocol. Another one fourth (25%) of each harvested
sample was subsequently thawed, subjected to five addi-
tional freeze/thaw cycles for cell lysis, and loaded into a
microtiter plate along with standards generated from
Lambda DNA. PicoGreen (Invitrogen) reagent was then
added to all wells to measure DNA content. Absorbance
(MMP-2) and fluorescence (DNA) measurements were
made with a SpectraMax M5 plate reader (Molecular
Devices, Sunnyvale, CA, USA). All measured MMP-2
protein levels were normalized to DNA content from
the corresponding sample, determined by using Pico-
Green, to examine comparable protein knockdown for
each population.
For quantitative RT-PCR, the remaining 50% of each
thawed sample was used for RNA isolation (RNeasy
Micro; Qiagen, Inc., Valencia, CA, USA). Total RNA was
then reverse transcribed (Ambion/Applied Biosystems,
Austin, TX, USA), and the resulting cDNA was used for
SYBR Green-based real-time PCR (MyiQ; Bio-Rad Labora-
tories, Hercules, CA, USA) to quantify expression of
GAPDH and MMP-2. Primers for each were designed for
rat genes (Table 2) by using Primer3 software [17]. Results
were analyzed by using the ΔΔCt method [18]. These
ΔΔCt values were then expressed as relative changes in
mRNA levels (fold difference) through the exponential
relation 2-ΔΔCt. All gene-expression data were statistically
analyzed (SPSS 14.0, Chicago, IL, USA) by independent-
sample t tests (critical significance level, a = 0.05), com-
paring the experimental condition with wild-type controls
to determine whether treatments had an effect on MMP-2
gene expression.
Gelatin films
A 5% (wt/vol) gelatin solution was pipetted onto glass
slides and allowed to air dry. Once cooled, the slides
were chemically crosslinked in 4% formalin for 1 hour
at room temperature, washed extensively with sterile
PBS, and then stored overnight in PBS at 4°C. The next
day, the PBS was removed and slides were equilibrated
in complete cell culture media for 30 minutes before
cell seeding.
Separate populations of AF cells infected with the most
effective of the five shRNA constructs against MMP2
(hereafter designated shMMP2), and the nonsense
shRNA construct (shNon) were treated with blasticidin
to obtain pure populations of transduced cells. Trans-
duced cells (n = 4 for shMMP2 and shNon each) and
noninfected control cells (n = 4) were seeded onto the
films at densities of approximately 200,000 cells/film.
The cell suspension was allowed to settle for 30 minutes
before cell-culture media was added. Gelatin films with-
out cells served as negative controls (n = 4). After 4 days
in normal culture conditions, media was removed from
the dish, and films were rinsed once with PBS, stained
with 1% Ponceau S for 1 minute, and washed with DI
water for 5 minutes on a shaker. Each replicate of gelatin
films was stained in parallel and imaged immediately
after staining under identical exposures to standardize
comparisons. Extent of degradation of gelatin films was
quantified by using Image J (National Institutes of
Health, Bethesda, MD, USA). In brief, images were first
segmented by thresholding to distinguish degraded
(white) from nondegraded (red) regions. The areas of
these regions were then used to calculate a percentage
degradation equal to the ratio of degraded area to total
area in each field of view. Statistical analysis (SPSS) was
performed by using a Kruskal-Wallis test with Games-
Howell post hoc analysis.
Collagen gels
Three-dimensional type I collagen gels were made from
rat-tail collagen (BD Biosciences, San Jose, CA, USA) at
a concentration of 3 mg/ml by following the manufac-
turer’s protocols. All components were prechilled and
sterile. In brief, the collagen I stock solution was diluted
in 10× PBS (Gibco/Invitrogen), sterile water, and 1N
NaOH to achieve a final concentration of 3 mg/ml col-
lagen in 1× PBS at pH 7.4. The collagen solution was
kept on ice until use.
AF cells were infected with shMMP2 or shNon virus,
as described previously. Two separate populations of
Table 2 Sequences of primers used for RT-PCR analysis
Gene name Forward and reverse primers GenBank accession no. Length of product (bp)
GAPDH 5 -AACCCATCACCATCTTCCAG-3 NM_017008 197
5 -GTGGTTCACACCCATCACAA-3
MMP2 5 -AGCTCCCGGAAAAGATTGAT-3 NM_031054 180
5 -TCCAGTTAAAGGCAGCGTCT-3
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cells were used for each of the two viruses, one of which
was treated with blasticidin to obtain a pure population
of only transduced cells, whereas the other was used as
a mixed population of transduced and noninfected cells
(n = 3 for each). Noninfected cells served as positive
control (n = 3), with collagen gels without cells (n = 3)
serving as negative control. Cells were trypsinized, pel-
leted, and resuspended in collagen solution at 500,000
cells/ml. The collagen-cell solution was pipetted into
custom-made dog-bone-shaped molds (3 mm thick),
fabricated to be 15 mm in width at the grips with a 5-
mm-wide × 10-mm-long gauge region, placed in petri
dishes. Polypropylene mesh (Small Parts, Inc., Logan-
sport, IN, USA) with approximately 300-μm pore size
was embedded in the collagen at each end of the mold
for gripping. Collagen gel constructs were incubated for
90 minutes at 37°C to allow polymerization, and then
placed in six-well plates in free-floating culture with
complete media. Gels were cultured for 7 days, at which
point, they were used either for mechanical testing to
ascertain changes in material properties, or fixed for his-
tology to evaluate structural changes.
Mechanical testing and histology
For mechanical testing, gels were removed from culture,
and their widths and thicknesses at the gauge region
were measured by using calipers. Gels were clamped on
each end at the mesh, and creep testing was performed
in tension by using hanging weights (Figure 1). An
initial weight of 1.5 g was added, followed by increments
of 0.5 g at 2-minute intervals until failure. For each spe-
cimen, applied engineering stress was calculated by
using cross-sectional areas measured before loading.
Deformations were captured by using a video system,
and engineering strain computed in the gauge region by
manual analysis of individual image frames. Mechanical
viscoelastic behavior was quantified by fitting data to
the standard linear viscoelastic solid-model equation for
creep loading (Eq 1) by using MATLAB (Mathworks,
Natick, MA, USA) to obtain values for parameters E1
and E2 (measures of elasticity), and μ (measure of visc-
osity).


















The short-term effective modulus (that is, as t ® 0),
E1 + E2; the long-term effective modulus (that is, as t
®∞), E2; the viscous parameter, μ; and the stress at col-
lagen-gel rupture were used for comparison among
experimental groups. One-way analysis of variance with
Tukey post hoc tests was performed (SPSS) to determine
whether differences among groups were statistically sig-
nificant (a = 0.05).
For histology, gels were fixed overnight in 10% buf-
fered formalin. Samples were then dehydrated through
sequential ethanol baths, cleared in xylene, and infil-
trated with paraffin. Paraffin blocks were cut to obtain
6-μm sections, which were stained with Safranin-O/Fast
green to evaluate changes in collagen structure.
Results
Disruption of mechanical integrity of the AF enhances
MMP-2 expression
We previously presented data showing localized MMP-2
activation when murine caudal discs are subjected to
compressive loads that induce degenerative changes in
the AF [15] (images reproduced in Figure 2). After our
recent findings of greater AF disorganization caused by
needle-puncture injury-induced IVD depressurization
[16], we postulated that MMP-2 might be involved in
these observed degenerative changes as well. At 2
weeks, we detected strong immunopositivity for MMP-2
in rat caudal IVDs punctured with 18-g hypodermic
needles, and distinctly weaker staining in 22-g and 26-g
Figure 1 Schematic representation of collagen gel mechanical
testing. Collagen gels were clamped on each end at the mesh, and
creep testing was performed in tension by using hanging weights.
An initial weight of 1.5 g was added, followed by increments of 0.5
g at 2-minute intervals until failure. The cross-sectional area,
measured before loading, was used to calculate applied engineering
stress, and analysis of deformations in individually captured frames
was used to calculate the engineering strain. Mechanical viscoelastic
behavior was quantified by fitting data to the standard linear
viscoelastic solid-model equation for creep loading.
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punctured discs, which were similar to nonpunctured
controls (Figure 3). Based on these results, we sought to
investigate the functional role of MMP-2 in cell-
mediated collagen remodeling by AF cells.
MMP2 expression can be silenced in primary AF cells
through stable RNA interference
To elucidate the role of MMP-2 in matrix organization,
we set out to develop an experimental system for silen-
cing MMP-2 in rat IVD cells to complement our in vivo
studies. After constructing five lentiviral vectors for
expressing shRNA to target MMP2, designated
shMMP2a-e, and a nonsense control shNon (Table 1),
we performed a preliminary screen to identify an effec-
tive silencing construct (data not shown). We examined
the knockdown of MMP2 expression in (a) mixed
(transduced and nontransduced) populations, (b) pure
(blasticidin-selected) populations, and (c) long-term cul-
tures of pure populations. All constructs, except
shMMP2a, led to decreased mRNA and protein levels,
as determined with qRT-PCR and MMP-2 activity assay,
respectively. In Experiment 1, the mixture of transduced
and nontransduced cells exhibited downregulation,
peaking at 4 days after infection, but then progressively
climbed higher through 10 days, presumably because of
proliferation of nontransduced cells. In Experiments 2
and 3, downregulation remained more consistent over
time. Overall, shMMP2c and d were more successful in
knocking down gene expression compared with the
other constructs, with up to 80% silencing observed for
both. Protein levels for shMMP2b-e were all markedly
lower than shNon controls. Based on the composite
data, we selected shMMP2d (hereafter designated
shMMP2) for use in subsequent experiments.
Replicates using three additional independent primary
cell isolations (n = 3) were then performed by using
shMMP2 and shNon to validate results of the screening
experiments. As before, compared with time-matched
wild-type cells, blasticidin-selected cells transduced with
shMMP2 contained significantly lower mRNA (P < 0.03;
Figure 4a), as well as significantly lower cell-associated
(P < 0.02; Figure 4b) and secreted levels of MMP-2 (P <
0.05; Figure 4c). At each time point, all mixed popula-
tions of shMMP2-infected cells and shNon-infected cells
were not different from corresponding wild-type
controls.
RNAi of MMP2 expression inhibits local matrix
degradation in AF cells
To determine the functional effects of MMP2 RNAi, AF
cells were plated on gelatin films to examine the extent
and localization of degradative processes. After culture for
4 days, blank gelatin films (negative control) stained homo-
geneously red with Ponceau S (Figure 5a). In contrast,
those seeded with noninfected control AF cells showed
extensive degradation of the gelatin immediately surround-
ing the cells (Figure 5b). These areas appeared lighter pink
to white, compared with the darker red-stained gelatin in
Figure 2 Static compression induces matrix metalloproteinase 2 (MMP-2) activation. Immunohistochemical staining using an antibody
(CA719E3C; Labvision, Fremont, CA, USA) that recognizes only the latent MMP-2 zymogen in nonloaded (left) and loaded (right) IVDs. These data
are unpublished, but presented in a poster [15]. The loss of positive staining from cells of loaded discs coincided with previously observed
increases in activation of MMP-2, as determined with enzyme-linked immunosorbent assay (ELISA) [10].
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areas farther away from cells. In films seeded with cells
transduced with shMMP2, only very diffuse degrees of
degradation were observed (Figure 5c). Films seeded with
cells transduced with shNon exhibited patterns similar to
those of noninfected controls, in which focal degradation
occurred only immediately surrounding cells, although the
degree of degradation was less (Figure 5d). Quantification
of gelatin films verified visual results (Figure 5e), with non-
infected cells and shNon-transduced cells having similar
percentages of decrease in staining (10.1% and 10.7%,
respectively), whereas shMMP2-transduced cells showed
minimal change in staining (0.5%), significantly lower than
both noninfected controls (P = 0.001) and shNon-trans-
duced cells (P = 0.002). No clear differences were observed
in the staining intensity of gelatin films away from cells,
suggesting that MMP-2 is most effective in localized cell-
mediated degradative processes.
Collagen remodeling is impaired in AF cells deficient in
MMP-2
The ability for AF cells to reorganize and contract col-
lagen gels was strongly diminished by MMP2 knock-
down. Histologic staining of blank gels revealed a
homogeneously porous structure throughout the gel
(Figure 6a). In contrast, gels with noninfected control
cells contained much denser regions of collagen sur-
rounding cells, which were well integrated into the
matrix. Collagen appeared to be organized into bundled
structures throughout the entire gel (Figure 6b). In gels
containing shMMP2-transduced cells, however, only
minor differences in appearance were noted compared
with blank gels (Figure 6c). Collagen remained free of
fibrillar bundles, and was more homogeneously porous.
Notably, cells were rounded and did not appear to inter-
act with the collagen matrix. Gels containing shNon
Figure 3 Transannular puncture injury upregulates matrix metalloproteinase 2 (MMP-2). Immunohistochemical staining of MMP-2 in rat
caudal discs subjected to transannular punctures by using hypodermic needles (18-g, 22-g, and 26-g) or subjected to sham surgery (no
puncture). Although AF cells in all tissue sections exhibited some immunopositivity, more positive cells were found, and the qualitative intensity
of staining was markedly higher in punctured discs, particularly for 18-g needles. We previously showed that 18-g hypodermic needle punctures
are associated with a greater incidence of degenerative changes in the AF [16].
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transduced cells also contained restructured collagen
fibers with denser staining around the cells (Figure 6d).
Those embedded with mixed populations of cells exhib-
ited qualities similar to noninfected controls, but
possessed areas containing rounded and unattached
cells (Figure 6e).
Despite the striking histologic differences in collagen
microstructure observed in the shMMP2 group compared
Figure 4 Stable silencing of matrix metalloproteinase 2 (MMP-2) by using shRNA-mediated RNAi. Silencing of MMP2 in primary rat caudal
annulus fibrosus (AF) cells at 4 and 10 days after lentivirus infection, with and without treatment with blasticidin to select for pure populations
of transduced cells. (a) Relative expression of treatment groups compared with noninfected controls, as quantified with real-time RT-PCR. At 4
and 10 days, MMP2 transcript levels were significantly decreased by 70% and 88%, respectively, in blasticidin-treated cultures (*P < 0.03). (b) Total
protein levels for MMP-2 in cell lysates and (c) in conditioned media. At 10 days, total MMP-2 is 95% and 90% lower (*P < 0.05) in blasticidin-
treated cell lysates and culture media, respectively, compared with that in noninfected controls (Cells).
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with both noninfected and shNon, MMP2 silencing did
not correspondingly affect collagen gel properties on the
larger scale. In terms of macroscopic appearance, blank
gel construct size remained the same size through 7 days
of culture, whereas gels embedded with noninfected AF
cells contracted approximately 83% relative to their origi-
nal size. Gels embedded with cells transduced with
shMMP2 contracted to a lesser degree (18%) than did gels
with cells transduced with shNon (31%).
With respect to mechanical behavior, trends among
groups were mixed. Noninfected wild-type AF cells signifi-
cantly increased rupture stress of collagen gels (Figure 7a)
compared with blank gels (P = 0.011), consistent with the
notion that fibroblasts remodel and strengthen collage-
nous matrices. However, both shMMP2 and shNon con-
trol groups were unable to improve the rupture stress of
collagen gels; values were comparable to acellular gels and
were also significantly lower than those embedded with
noninfected cells (P < 0.05). No clear trends in short-term
(E1 + E2) and long-term (E2) effective moduli of collagen
gels were discernible, with differences among groups not
statistically significant (Figure 7b, c). The act of seeding
cells for all groups into collagen gels, however, resulted in
a significant decrease (P < 0.05) in the viscous coefficient,
μ (Figure 7d) for all groups. Noninfected AF cells and
shNon transduced cells trended toward lower values com-
pared with shMMP2 cells, but these differences were not
statistically significant.
Discussion
This study demonstrated that MMP2 expression is sti-
mulated in the AF of IVDs subjected to overload or
puncture injury in rodent caudal discs, and strongly sup-
ports the notion that MMP-2 plays a significant func-
tional role in the degenerative changes previously
observed in both animal models [16,19]. In particular, we
showed that silencing MMP2 expression all but elimi-
nated gelatinase activity in AF cells and profoundly com-
promised their ability to remodel collagen matrices. We
also demonstrated that, similar to tumor invadopodia
[20-23], MMP-2 preferentially functions in a localized
region surrounding AF cells, rather than being secreted
and acting at a distance. Contrary to our expectations,
the impaired ability of AF cells to degrade and remodel
their local microstructure did not translate to the macro-
scale characterization of the collagen-gel mechanical
Figure 5 shRNA construct against matrix metalloproteinase 2 (MMP-2) (shMMP2) inhibits localized gelatin degradation surrounding
annulus fibrosus (AF) cells. Microscopy images of gelatin films seeded with (a) no cells, (b) noninfected AF cells, (c) cells transduced with
shMMP2, and (d) cells transduced with shNon. Films were stained at 4 days in culture with Ponceau S and visualized immediately. Scale bars
represent 200 μm. All images were taken at 100×. Films with no cells (a) stained evenly red, whereas films seeded with noninfected AF cells (b)
showed focal degradation of gelatin in the areas immediately surrounding cells, which is shown by the lighter-stained regions. Similar results are
seen with cells transduced with shNon (d). Cells transduced with shMMP2 (c) show little to no focal degradation of gelatin, implying that MMP-2
is directly involved in gelatin breakdown. (e) Quantification of gelatin degradation. Gelatin films seeded with noninfected control AF cells and
shNon-transduced cells were similar in percentage degradation of gelatin, which corroborated visual results. Compared with the shMMP2-
transduced cells, degradation was significantly higher in the noninfected AF control group (P = 0.001) and shNon-transduced group (0.002), as
observed visually.
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properties. The lack of clear trends indicates that bulk
collagen-gel properties depend on more than just col-
lagen microstructure. Others have similarly shown that
collagen fiber alignment does not fully explain the direc-
tion-dependent material properties of collagen gels [24].
Various matrix-degrading enzymes have been found to
be expressed at higher levels in degenerate human discs
[2,9,25-29]. Although the biochemical aspects of MMP
function have been elucidated, their specific functional
roles in the multifaceted nature of the disorder are not
well understood. For instance, it has been shown that
MMPs can contribute not only to matrix degradation,
but also to inflammatory conditions, innervation, and
apoptosis [5,30,31] all of which have been observed in
Figure 6 shRNA construct against matrix metalloproteinase 2 (MMP-2) (shMMP2) impairs annulus fibrosus (AF) cell-mediated
remodeling of collagen gels. Histology images of collagen gels containing (a) no cells, (b) nontransduced AF cells, (c) a pure population of
cells transduced with shMMP2, (d) a pure population of cells transduced with shNon, and (e) a mixed population of shMMP2-transduced and
nontransduced cells. All gels were cultured for 7 days. Images for (a) through (d) were taken at 400×; scale bars represent 50 μm. Image for (e)
was taken at 100×; scale bar represents 200 μm. Noninfected AF cells (b) and shNon-transduced cells (d) were shown to restructure collagen
gels. These cells appeared elongated and anchored to the fibers. Cells transduced with shMMP2 (c) appeared similar to gels without cells (a),
with little to no restructuring of the collagen network and rounded cells. In gels containing mixed populations of cells (e), collagen fibers were
reorganized but rounded cells were clearly visible without reorganization of fibers in their immediate surroundings.
Figure 7 shRNA construct against matrix metalloproteinase 2 (MMP-2) (shMMP2) inhibits strengthening of collagen gels by annulus
fibrosus (AF) cells. Parameters obtained from mechanical testing of collagen gels. (a) Rupture stress of collagen gels seeded with wild-type
noninfected cells was significantly higher than that of acellular gels, gels populated with shNon-transduced cells, and gels populated with
shMMP2-transduced cells (P < 0.05). (b) Short-term and (c) long-term moduli were lower in cell-seeded collagen gels but not significantly
different from acellular gels. (d) Collagen gels seeded with cells possessed significantly lower viscous coefficients than did acellular gels (P <
0.05).
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DDD. Although the precise coordination of the molecu-
lar events behind degenerative tissue remodeling
remains unclear, demonstrating that MMP-2 is critical
for localized matrix turnover by AF cells serves as an
important step toward mechanistic understanding of
DDD.
The observed effects in AF cells are consistent with
the putative role of MMP-2 in other systems in vivo.
Because gelatinases exhibit much greater enzymatic
activity on denatured collagen than on native collagen
[32], they are believed to work alongside other matrix-
degrading enzymes in mediating radical changes in the
ECM by removing bulk denatured collagen material
(gelatin). Although MMP-2 is considered in most circles
to function in the secondary processing of collagen, stu-
dies have shown its ability to cleave intact triple-helical
collagen with some efficiency [5,33]. It is interesting to
speculate whether MMP-2 might also serve a collageno-
lytic capacity in our collagen gel preparations, because
the inability for shMMP2-transduced cells to remodel
the gels was so dramatic. Further studies manipulating
collagenase activity are needed to investigate the relative
collagenolytic and gelatinolytic roles that potentially
underlie MMP-2 function.
Changes mediated by MMP-2 can be either physiolo-
gic or pathophysiologic in context. For instance, MMP-2
and -9 have been implicated not only in development
and repair, but also in pathologies of the tracheal gland
[32], renal system [34,35], tumors [20,30,36], bone
[37-39], and circulatory system [40,41], among others.
In the current study, knocking down MMP-2 both
impaired the localized degradation of gelatin and inhib-
ited AF cells from remodeling the collagen matrix. This
was evident in the histologic structure and contraction
of collagen gels. Despite the known association between
gelatinase activity and collagen gel remodeling, until
now, no direct evidence suggested that these effects are
directly coupled in AF cells.
This ambiguity stems in part from a complex relation
that has been observed to exist among ECM-related
cues, actin cytoskeletal organization, and MMP-2 activa-
tion. It has long been observed that cells can cause con-
traction of native collagen gels through reorganization
of collagen fibrillar structure [42]. Generally, contraction
of gels is accompanied by MMP-2 activation [43-47],
which is thought to be linked with the suppression of
stress fibers by collagen gel deformability [45,46,48].
Studies have also demonstrated that integrin binding is
another critical factor in potentiating MMP-2 function
[21,22,45,49-52].
Although these previous studies demonstrate an out-
side-in phenomenon in the regulation of MMP-2 activa-
tion by the collagen microenvironment, our data suggest
that effects may be bidirectional. We found that pure
populations of MMP-2-deficient AF cells remained
rounded in collagen gels and were unable to remodel
them, although cells remained adherent to gelatin films
over several days. Thus, it appears that MMP2 expres-
sion may have profound influence over actin-cytoskele-
ton-dependent collagen gel remodeling, but no effect on
cell-collagen binding, presumably via b1 integrins.
Furthermore, it suggests that collagen gel contraction is
more directly influenced by cytoskeletal organization
than integrin ligation, which may be a necessary, but
not sufficient, condition.
In terms of IVD physiology, our findings support the
pursuit of further in vivo investigation. Evidence from
the literature points to a potentially important role of
MMP-2 in degradative changes in the AF. Across var-
ious species and insult techniques, animal models of
degenerative changes in the IVD have demonstrated an
association of MMP-2 with gross morphologic changes
in the AF [3,10,53], which parallels observations in
human discs during development and pathogenesis
[2,27-29]. Consistent with these other studies, our data
in mice and rats show that MMP-2 activity could
increase relatively early in response to injurious load
and annular puncture [16,19], suggesting possible invol-
vement in the initial phases of degradation.
Experiments using in vitro cell-culture models provide
some insight into the potential functional significance of
MMP-2. Silencing MMP2 in primary AF cells abolished
gelatinolytic activity in the vicinity of cells, implicating
MMP-2 as the primary physiologic gelatinase responsi-
ble for localized breakdown of gelatin but of little rele-
vance in distant matrix degradation. This observation is
consistent with previous reports in the literature by
others, that negligible MMP-9 is expressed in nonher-
niated human IVDs [28]. Collagen gel experiments
underscore the functional significance of MMP-2 in
structural reorganization of the ECM. Noninfected AF
cells were able to modify the existing collagen scaffold
into a more fibrous compact structure, resulting in gels
that exhibited higher strength and lower viscosity, pre-
sumably due in part to the ability to remove denatured
collagen. It also is possible that MMP-2 may contribute
to the cells’ ability to modify their biophysical environ-
ment through contraction, migration, and manipulation
of collagen fibrils.
Several technical observations were also made during
the course of this study. In our experiments, five shRNA
sequences were tested for effectiveness in silencing
MMP2 in rat AF cells. As expected, some constructs
were more effective in silencing MMP2 than were
others. It is known that siRNAs targeting different
regions of the same gene vary markedly in their effec-
tiveness [14], which depends on factors such as the sec-
ondary structure of the mRNA target, presence of the
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RNA-binding proteins, and thermodynamic stability of
the duplex [14,54]. In mixed-populations cultures, it is
also possible that the transduced and nontransduced
populations exhibit differences in proliferation rates,
although we did not measure this directly. It was, there-
fore, not unexpected that the level of knockdown might
change over time.
Treating cells with blasticidin to obtain a pure popula-
tion of only transduced cells eliminated any potential
masking effects by nontransduced cells. Therefore, it
was expected that the pure population would exhibit
higher levels of knockdown compared with a mixed
population. Instead, we observed less suppression of
transcript levels in Experiments 2 and 3 for all of our
constructs. It is possible that the 10-day blasticidin
treatment used to kill nontransduced cells in these
experiments may nonspecifically alter expression of
other genes, as antibiotics in culture could interfere with
multiple metabolic processes [55]. Despite the reduced
silencing observed at the mRNA level, we continued to
observe almost no protein expression.
Even though the shNon contained a scrambled
sequence, some level of knockdown was observed in
these cells as well. It is known that the interferon
response may be triggered in the process of cell trans-
fection with a viral vector [14,54] and may cause overall
changes in the gene-expression profile in cells as well
[56]. These factors together could lead to some level of
gene knockdown observed in cells transduced with the
shNon vector. In addition, some debate exists as to the
specificity of sequences required for effective RNAi [57].
Various bases in the scrambled nonsense sequence may
be able to match the MMP2 mRNA found in cells caus-
ing some knockdown effect. Compared with the non-
sense construct, however, shMMP2 was significantly
more effective in reducing mRNA and protein levels.
Therefore, the chosen sequence for shMMP2 was con-
sidered effective for use in future RNAi experiments.
Although more work is needed, elucidating the func-
tional roles of degradative enzymes in degenerative
remodeling of the disc ECM contributes to the identifi-
cation of potential targets for gene therapy. RNAi tech-
nology offers the advantage of stable silencing of
catabolic factors, which can be of therapeutic value in
treating disc degeneration. To this extent, lentiviral vec-
tors have provided an advancement in RNAi and offer
the means to achieve significant levels of gene transfer
both in vitro and in vivo [54]. Various studies have used
siRNAs for RNAi in IVD cells [58,59], but to our knowl-
edge, this study is the first to use shRNAs to ascertain
the functional role of a molecule putatively involved in
disc degeneration. MMP2 as a gene-therapy target has
already been studied in vivo by using animal models as
a strategy to treat tumors. In nude mice, siRNAs against
MMP2 resulted in decreased tumor invasion, migration,
and angiogenesis, with a 60% reduction in tumor size
[60,61]. This approach allows only transient downregu-
lation of gene expression, making it difficult to adapt for
therapeutic purposes. However, shRNA delivery can
allow long-term studies to determine the functional role
of genes relevant to intervertebral disc degeneration,
such as MMP2.
Conclusions
Taken together, results from this study suggest that the
increased presence of MMP-2 in animal models of disc
degeneration may be associated with the degradative
changes that are observed in the AF. Whether a similar
relation might exist in degradative changes in human
DDD remains to be determined. By using RNAi, we
showed that MMP-2 functions as the primary gelatinase
and is used by AF cells for degrading the local sur-
rounding matrix. Notably, in the absence of MMP-2,
collagen remodeling is significantly impaired, suggesting
that it may play a significant role in collagen turnover
and structural alterations in the AF. This mechanism
could offer one avenue for therapeutic intervention
against degenerative disc disease.
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